200012:SZSECSG Holding Co., Ltd. Analysis
Data as of 2026-08-01 - not real-time
HK$1.48
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
CSG Holding is trading at a trailing PE of 148 while its forward PE collapses to about 2.3, indicating that the market is pricing in a sharp earnings rebound. Price-to‑book stands at just 0.29 and the forward EPS of 0.65 suggests substantial upside relative to the current price of 1.48 HKD. The stock shows a bullish MACD histogram and a neutral RSI around 52, yet it remains below its 200‑day SMA of 1.63, keeping the longer‑term trend bearish. Volatility is elevated at roughly 46% over the past 30 days, but beta is low at 0.36, implying limited market‑wide price swings. The balance sheet is leveraged, with a debt‑to‑equity ratio over 80 and total debt more than three times cash, though operating and free cash flow remain positive and the dividend payout is modest at 14% of earnings, yielding 1.55%. Support near 1.37 and resistance around 1.64 frame a relatively tight trading range, while stable volume suggests no immediate liquidity stress. Overall, the combination of deep valuation discounts, forward earnings upside, and a sustainable dividend makes the stock attractive, but the high leverage and cyclical exposure to Chinese building‑materials demand temper enthusiasm.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish MACD signal amid bearish long‑term trend
- High short‑term volatility and proximity to support
- Elevated leverage limiting upside potential
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE of ~2.3 indicating strong earnings upside
- Low price‑to‑book and attractive dividend yield
- Positive operating and free cash flow supporting dividend sustainability
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Structural exposure to renewable‑energy glass and solar segments
- Continued high debt levels and cyclicality of building‑materials demand
- Stable beta and modest currency risk in a Chinese‑centric business
Key Metrics & Analysis
Financial Health
Revenue Growth-2.60%
Profit Margin0.08%
P/E Ratio148.0
ROE-0.05%
ROA0.25%
Debt/Equity81.10
P/B Ratio0.3
Op. Cash FlowHK$1.1B
Free Cash FlowHK$497.3M
Technical Analysis
TrendBearish
RSI51.7
SupportHK$1.37
ResistanceHK$1.64
MA 20HK$1.46
MA 50HK$1.47
MA 200HK$1.63
MACDBullish
VolumeStable
Fear & Greed Index92.88
Valuation
GradeUndervalued
TypeBlend
Dividend Yield1.55%
Risk Assessment
Beta0.36
Volatility46.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.